1 source · first reported 4d ago
The US Army is creating a biotech startup accelerator to develop biological defense technologies, with up to $95 million in funding and a potential follow-on contract worth $500 million. The accelerator aims to rapidly transition technologies from laboratory to battlefield.
This initiative highlights the Army's focus on leveraging biotechnology for defense applications, which could lead to significant advancements in biological defense capabilities. The substantial funding allocated to this project underscores the importance of this effort.
How this story unfolded across sources, oldest first.